Open access peer-reviewed chapter

GPR119 Agonists: A Novel Strategy for Type 2 Diabetes Treatment

By Xiaoyun Zhu, Wenglong Huang and Hai Qian

Submitted: November 28th 2011Reviewed: May 5th 2012Published: January 23rd 2013

DOI: 10.5772/48444

Downloaded: 3311

© 2013 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Xiaoyun Zhu, Wenglong Huang and Hai Qian (January 23rd 2013). GPR119 Agonists: A Novel Strategy for Type 2 Diabetes Treatment, Diabetes Mellitus Oluwafemi Oguntibeju, IntechOpen, DOI: 10.5772/48444. Available from:

Embed this chapter on your site Copy to clipboard

<iframe src="http://www.intechopen.com/embed/diabetes-mellitus-insights-and-perspectives/gpr119-agonists-a-novel-strategy-for-type-2-diabetes-treatment" />

Embed this code snippet in the HTML of your website to show this chapter

chapter statistics

3311total chapter downloads

4Crossref citations

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

The Role of Nutrition in the Management of Diabetes Mellitus

By Olabiyi Folorunso and Oluwafemi Oguntibeju

Related Book

First chapter

Lipid Profile, Antidiabetic and Antioxidant Activity of Acacia ataxacantha Bark Extract in Streptozotocin-Induced Diabetic Rats

By Rotimi O. Arise, Aderounmu I. Ganiyu and Oluwafemi O. Oguntibeju

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

+3,550 Open Access Books

+57,400 Citations in Web of Science

+108,500 IntechOpen Authors and Academic Editors

+560,000 Unique visitors per month

More about us